3'-fluoro-4'-hydroxy-3-methylbiphenyl-4-carbonitrile | 716344-35-3

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 3'-fluoro-4'-hydroxy-3-methylbiphenyl-4-carbonitrile
• CAS: 716344-35-3
• 化学式: C₁₄H₁₀FNO
• 分子量: 227.238
• InChiKey: IHQWXHZNSDRGIO-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.38
• 重原子数：
  17.0
• 可旋转键数：
  1.0
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.07
• 拓扑面积：
  44.02
• 氢给体数：
  1.0
• 氢受体数：
  2.0

反应信息

• 作为反应物：
  描述：

  3'-fluoro-4'-hydroxy-3-methylbiphenyl-4-carbonitrile 在 二异丁基氢化铝 作用下， 以 甲苯 为溶剂， 反应 3.5h， 以44%的产率得到3'-fluoro-4'-hydroxy-3-methylbiphenyl-4-carbaldehyde
  参考文献：
  名称：

  ERβ Ligands. Part 2: Synthesis and structure–activity relationships of a series of 4-hydroxy-biphenyl-carbaldehyde oxime derivatives

  摘要：

  A series of biphenyl carbaldehyde oximes (6) was prepared and shown to have significant selectivity for the estrogen receptor-beta (ERbeta). The exploitation of the oxime moiety as a hydrogen bond donating group, which mimicked the C-ring of genistein makes these compounds unique. Molecular modeling studies showed the oxime moiety hydrogen bonding to the histidine residue, which was supported by the structure-activity relationships. The most potent compounds in this study had IC50 values in a radio-liaand binding assay of between 8-35 nM. Among the most selective compounds were 6i and 6s (49- and 31-fold ERbeta selective, respectively). (C) 2004 Elsevier Ltd. All rights reserved.

  DOI：

  10.1016/j.bmc.2004.03.028
• 作为产物：
  描述：

  3-氟-4-甲氧基苯硼酸 在 三溴化硼 、 potassium carbonate 作用下， 以 二氯甲烷 、 水 为溶剂， 反应 12.25h， 生成 3'-fluoro-4'-hydroxy-3-methylbiphenyl-4-carbonitrile
  参考文献：
  名称：

  噻吩-联苯-DAPY HIV-1非核苷逆转录酶抑制剂的构象限制设计

  摘要：

  构象限制是开发DAPY型非核苷逆转录酶抑制剂（NNRTIs）的一种有前途的策略。本文中，设计并合成了十八种噻吩-联苯-DAPY衍生物，作为有效的HIV-1 NNRTIs，其中引入了卤素和甲基以探索构象约束效应。分子对接和动态模拟分析表明，联苯环不同位置的取代基引起不同的二面角和结合构象，进一步解释了它们的抗病毒活性。2'-氟和3'-氯取代可与RT酶的相邻残基形成静电或卤素键相互作用。2'-甲基有助于扩大联苯环的二面角，并位于一个充满空间的疏水口袋中。具有两个甲基的22和23对WT-1被WT HIV-1感染的MT-4细胞（分别为EC 50  = 14和17 nM）和RT酶（分别为EC 50  = 27和42 nM）表现出强大的生物学活性。特别是，23种药物的毒性比 伊曲韦林低得多（CC 50 = 264.19μM），选择性指数高（SI = 18,564）。综上所述，提出了进一步构筑DAPYs

  DOI：

  10.1016/j.ejmech.2019.111603

文献信息

• Ligand-Based Design of Nondimethylphenyl-Diarylpyrimidines with Improved Metabolic Stability, Safety, and Oral Pharmacokinetic Profiles
  作者：Yali Sang、Sheng Han、Christophe Pannecouque、Erik De Clercq、Chunlin Zhuang、Fener Chen

  DOI：10.1021/acs.jmedchem.9b01446

  日期：2019.12.26

  A series of nondimethylphenyl-diarylpyrimidines with much lower cytotoxicities than their dimethyl analogues were developed. Compound B13 with a difluorobiphenyl moiety showed the highest antiviral activity against WT, mutant strains, and RT. The hydrochloride form of B13 exhibited an improved water solubility of 5.6 mu g/mL compared with ETR (<< 1 mu g/mL), better stability in human and rat liver microsomes, and a great oral bioavailability of 44%, making it promising as a drug candidate. In addition, no apparent toxicity was observed in the acute toxicity assay (2 g/kg) and HE staining.